Expressions of LOX and HIF-1 protein in breast cancer tissues and their clinical significance
Jianlun Liu
Abstract
Jianlun Liu
Abstract
OBJECTIVE:To study the expression of LOX and HIF-1 protein in human breast cancer tissues and explore the relationship between LOX expression and patient's age,tumor size,axillary node metastasis,clinical stage,HIF-1 protein expression.METHODS:The expressions of LOX and HIF-1 Protein in 56 cases of human breast cancer tissues,56 normal breast tissues and 20 cases of breast benign lesion tissues was detected by SP immunohistochemistry.RESULTS:The expression rate of LOX protein in breast cancer,normal breast tissues and breast benign lesion tissue were 48.21%(27/56),26.78%(15/56) and 20.00%(4/20),statistical difference was found among them(P=0.019).Statistical difference was found between breast carcinoma group,and benign lesion group(P=0.028).And no significant difference was found between normal breast tissues and benign lesion(P=0.519).The expression of LOX protein were associated with clinical stage(P=0.005),lymph node metastasis(P=0.042),but had no correlation with age and tumor size(P=0.182 and 0.058).The LOX protein had significant positive correlation with the HIF-1α protein expression in breast cancer(r=0.368,P=0.005).CONCLUSIONS:LOX protein expression is increased in breast cancer tumor tissues.LOX is related with clinical stage and lymph node metastasis.LOX and HIF-1α have a synergistic effect in breast cancer invasion and metastasis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To study the expression of LOX and HIF-1 protein in human breast cancer tissues and explore the relationship between LOX expression and patient's age,tumor size,axillary node metastasis,clinical stage,HIF-1 protein expression.METHODS:The expressions of LOX and HIF-1 Protein in 56 cases of human breast cancer tissues,56 normal breast tissues and 20 cases of breast benign lesion tissues was detected by SP immunohistochemistry.RESULTS:The expression rate of LOX protein in breast cancer,normal breast tissues and breast benign lesion tissue were 48.21%(27/56),26.78%(15/56) and 20.00%(4/20),statistical difference was found among them(P=0.019).Statistical difference was found between breast carcinoma group,and benign lesion group(P=0.028).And no significant difference was found between normal breast tissues and benign lesion(P=0.519).The expression of LOX protein were associated with clinical stage(P=0.005),lymph node metastasis(P=0.042),but had no correlation with age and tumor size(P=0.182 and 0.058).The LOX protein had significant positive correlation with the HIF-1α protein expression in breast cancer(r=0.368,P=0.005).CONCLUSIONS:LOX protein expression is increased in breast cancer tumor tissues.LOX is related with clinical stage and lymph node metastasis.LOX and HIF-1α have a synergistic effect in breast cancer invasion and metastasis.
Key concepts: Breast cancer, Immunohistochemistry, Medicine, Pathology, Clinical significance, Metastasis, Lymph node, Breast carcinoma